Throne Biotechnologies (Throne) is a clinical-stage therapeutic company with a disruptive stem cell technology that can fundamentally reverse type 1 diabetes (T1D), alopecia areata (AA) and other autoimmune diseases through

We are happy to announce that Throne Biotechnologies (Throne) is an awardee of the “2022’s Most Promising Leaders in Biotechnologies – USA” by Corporate Vision.

We are happy to announce that Throne Biotechnologies (Throne) is one of the awardees of the “20 Admired Companies Which Everyone Should Know in 2022" by Global Business Leaders magazine.

We are honored to announce that Throne Biotechnologies (Throne) is one of the awardees of the “20 Most Innovative Companies To Watch in 2022 “ by Global Radiance Review.

We sincerely appreciate all our investors who kindly care and support the Throne’s Crowdfunding Campaign at StartEngine, leading to the initiation of our clinical trials of Stem Cell Educator therapy

We sincerely appreciate all our investors who kindly care and support the Throne’s Crowdfunding Campaign at StartEngine, leading to the initiation of our clinical trials of Stem Cell Educator therapy. This

We are so thankful for all of our investors so far and sincerely appreciate all your generosities to support the clinical trials of Stem Cell Educator therapy to treat type

We are honored to announce that Throne Biotechnologies (Throne) is one of the awardees of the “5 Best BioTech Companies To Watch“ by The Silicon Review.